ascorbic-acid has been researched along with Arthritis--Rheumatoid* in 149 studies
3 review(s) available for ascorbic-acid and Arthritis--Rheumatoid
Article | Year |
---|---|
Micronutrients: oxidant/antioxidant status.
Potentially damaging species (reactive oxygen, nitrogen and chlorine species) arise as by-products of metabolism and as physiological mediators and signalling molecules. Levels of these species are controlled by the antioxidant defence system. Several components of this system are micronutrients (e.g. vitamins C and E) or are dependent upon dietary micronutrients (e.g. CuZn and Mn superoxide dismutase). The antioxidant defences act as a coordinated system where deficiencies in one component may affect the efficiency of the others. Oxidative stress may be an important factor in infection if micronutrients are deficient. Topics: Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Cardiovascular Diseases; Copper; Deficiency Diseases; Developing Countries; Disease Susceptibility; HIV Infections; Humans; Iron; Magnesium; Manganese; Micronutrients; Nutritional Status; Oxidative Stress; Virus Diseases; Vitamin E; Zinc | 2001 |
Clinical biochemical measurements in rheumatology.
Despite 50 years of intensive research in the field of RFs, autoimmunity and chronic inflammation, some of the serological tests used for measuring autoantibodies remain an anachronism. Clinical chemistry has the potential technology to provide the rheumatologist with automated quantitative antibody/antigen measurements. It can also widen the range of tests available for disease monitoring, which would be helpful in the management of the chronic rheumatic diseases. Traditional laboratory tests must be superseded by new developments, derived from fundamental research, if we are to improve the diagnosis and management of the rheumatic diseases. Topics: Acute-Phase Proteins; Antibodies, Antinuclear; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Biochemistry; Humans; Iron; Liver Function Tests; Rheumatoid Factor; Rheumatology; Trace Elements | 1988 |
Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease.
Reactive oxygen metabolic products derived from an activated NADPH oxidase present in the cell membrane of PMNs and mononuclear phagocytic cells play a critical role in the host's defense against bacterial infection. Recent studies have also demonstrated the ability of these toxic products to initiate eukaryotic cell injury and promote the development of the acute inflammatory responses. Experimental studies suggest that neutrophil-derived oxygen metabolites contribute to the development of the tissue injury associated with a variety of disease states, including emphysema, myocardial infarction, adult respiratory distress syndrome, immune complex-mediated vasculitis, and rheumatoid arthritis. Future studies to define further the mechanisms by which reactive oxygen-derived metabolic products mediate tissue injury will provide insight into the development of new therapeutic strategies for the modulation of disease states that are mediated by the recruitment and activation of PMNs. Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Autoimmune Diseases; Ceruloplasmin; Chemotactic Factors; Cricetinae; Cricetulus; Free Radicals; Humans; Immune Complex Diseases; Inflammation; Lipid Peroxides; Myocardial Infarction; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Oxidation-Reduction; Oxygen; Pancreatic Elastase; Peroxidase; Peroxidases; Peroxides; Phagocytosis; Pulmonary Emphysema; Respiratory Distress Syndrome; Superoxide Dismutase; Superoxides; Vasculitis; Vitamin E | 1985 |
5 trial(s) available for ascorbic-acid and Arthritis--Rheumatoid
Article | Year |
---|---|
Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients.
Excess generation of reactive oxygen species in damaged joints accelerates inflammatory responses in RA (rheumatoid arthritis) patients. The complementary effects of dietary antioxidant supplementation on the blood level of inflammatory mediators and the severity of the disease in RA patients were evaluated.. The study was conducted as a randomized, placebo-controlled, double-blind, three-treatment cross-over design trial. The participants visited the hospital as outpatients.. Twenty patients meeting the 1987 criteria for the classification of rheumatoid arthritis completed the study.. The subjects were randomized in three groups to receive one of following supplementation; quercetin+vitamin C (166 mg+133 mg/capsule), alpha-lipoic acid (300 mg/capsule) or placebo for 4 weeks (3 capsules/day). Each treatment period consisted of 4 weeks with 2 weeks of wash-out period before the subject starts next supplementation.. Serum levels of tumor necrosis factor-alpha(TNF-alpha), interleukin-1beta(IL-1beta), interleukin -6(IL-6), and C-reactive protein (CRP) were measured. The severity of disease was evaluated using Korean Health Assessment Questionnaire(KHAQ) and Visual Analogue Scale(VAS). Nutrient intake was measured at baseline and at the end of each intervention period.. The mean energy and nutrient intakes remained constant during study period. No significant differences were found in the serum concentrations of pro-inflammatory cytokines and CRP between treatments. The scores of disease severity measurements were not significantly different between treatments, although quercetin supplementation had a tendency to reduce VAS.. Dietary supplementation of antioxidants at 900 mg/day for 4 weeks did not change the blood biomarkers of inflammation and disease severity of RA patients under conventional medical treatments. Further considerations for dose-response relationships, duration of supplementation, and susceptible biomarkers are required. Topics: Adult; Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Biomarkers; C-Reactive Protein; Cross-Over Studies; Cytokines; Dietary Supplements; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Energy Intake; Female; Humans; Male; Middle Aged; Quercetin; Severity of Illness Index; Thioctic Acid; Vitamins | 2009 |
Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
To investigate in a double-blind placebo-controlled, parallel group study, the effects of a nutrient supplement, containing, among other ingredients, the omega-3 fatty acids eicosapentaenoic acid (1.4 g EPA), docosahexaenoic acid (0.211 g DHA), omega-6 fatty acid gamma-linolenic acid (0.5 g GLA) and micronutrients in patients with active rheumatoid arthritis (RA).. RA patients were randomized to receive either daily liquid nutrient supplementation or placebo for 4 months. The primary end point was the change in tender joint count at 2 and 4 months. Other clinical variables included swollen joint count, visual analogue scales for pain and disease activity, grip strength, functionality score and morning stiffness. Biochemical parameters included plasma concentrations of PUFA and vitamins C and E.. Outpatient university clinic.. In all, 66 patients enrolled, 55 completed the study. No significant change from baseline in tender joint count or any of the other clinical parameters was detected in either group. Patients receiving nutrient supplementation, but not those receiving placebo, had significant increases in plasma concentrations of vitamin E (P=0.015), and EPA, DHA and docosapentaenoic acid concomitant with decreases of arachidonic acid (P=0.01). Intergroup differences for PUFA and vitamin E were significantly different (P=0.01 and 0.03, respectively).. This double-blind, placebo-controlled study in RA patients did not show superior clinical benefit of daily nutrient supplementation with EPA, GLA and micronutrients at the doses tested as compared to placebo. The study adds information regarding doses of omega-3 fatty acids, below which anti-inflammatory effects in RA are not seen. Topics: Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; gamma-Linolenic Acid; Hand Strength; Humans; Male; Micronutrients; Middle Aged; Pain; Treatment Outcome; Vitamin E | 2004 |
Antioxidant status in rheumatoid arthritis and role of antioxidant therapy.
Oxygen free radicals have been implicated as mediators of tissue damage in patients of rheumatoid arthritis (RA). This study was designed to elucidate plasma oxidant/antioxidant status in rheumatoid arthritis, with the aim of evaluating the importance of antioxidant therapy in the management of this disease.. The study included 40 patients of rheumatoid arthritis who were randomly divided into two subgroups of 20 each. One group received conventional treatment for 12 weeks and in the other group conventional treatment was supplemented with antioxidants for the same duration. Twenty age- and sex-matched normal individuals constituted the control group. Blood samples of controls and patients were collected at the time of presentation and analyzed for total thiols, glutathione, vitamin C and malondialdehyde (MDA-marker of oxidative stress). The investigations were repeated in the patients after 12 weeks.. The blood concentrations of total thiols, glutathione and vitamin C were found to be significantly lower in rheumatoid arthritis patients as compared to healthy controls, while the concentrations of MDA were much higher. There was a statistically significant increase in the posttreatment concentrations of these antioxidants, along with a decrease in the concentrations of MDA.. The antioxidant defense system is compromised in rheumatoid arthritis patients. There is a shift in the oxidant/antioxidant balance in favor of lipid peroxidation, which could lead to the tissue damage observed in the disease. The results suggest the necessity for therapeutic co-administration of antioxidants along with conventional drugs to such patients. However, due to the limited number of cases included in this study, more studies may be required to substantiate the results and arrive at a definite conclusion, in terms of safety and efficacy of adding on antioxidant therapy for the treatment of RA. Topics: Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Female; Glutathione; Humans; Male; Malondialdehyde; Sulfhydryl Compounds | 2003 |
Ascorbic acid supplementation in the treatment of pressure-sores.
In a prospective double-blind controlled trial the effect of large doses of ascorbic acid on the healing of pressure-sores has been assessed. 20 surgical patients were studied, the pressure areas being assessed by serial photography and ulcer tracings. The mean ascorbic-acid levels in treated and non-treated groups one month after the start of treatment were 65.6 and 25.8 mug per 10-8 white blood-cells. In the group treated with ascorbic acid there was a mean reduction in pressure-sore area of 84% after one month compared with 42.7% in the placebo group. These findings are statistically significant (P less than 0.005) and suggest that ascorbic acid may accelerate the healing of pressure-sores. Topics: Aged; Arthritis, Rheumatoid; Ascorbic Acid; Ascorbic Acid Deficiency; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Fractures, Bone; Humans; Leukocytes; Male; Middle Aged; Paraplegia; Postoperative Complications; Pressure Ulcer; Prospective Studies; Vascular Diseases; Wound Healing | 1974 |
[Possibilities of intermittent therapy of progressive chronic polyarthritis].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Arthritis, Rheumatoid; Ascorbic Acid; Female; Fructose; Humans; Methods; Middle Aged; Phenylbutazone; Physical Therapy Modalities; Prednisone | 1971 |
141 other study(ies) available for ascorbic-acid and Arthritis--Rheumatoid
Article | Year |
---|---|
Rheumatologic manifestations with elevated levels of IL-6, IL-17A, and IL-23 in a patient with scurvy.
Symptomatic vitamin C deficiency, scurvy, is a relatively rare disease in developed countries, but it has been reported in patients with autism spectrum disorder or developmental delay who tend to have selective diets. Patients with scurvy often demonstrate musculoskeletal manifestations with unknown pathophysiology. Herein, we report a case of scurvy in an 11-year-old boy who presented with iron-deficiency anaemia, systemic osteomyelitis, myositis predominantly in the lower extremities, and right ventricular volume overload with mild pulmonary hypertension and was diagnosed with scurvy. He had a mild developmental disorder and a selective diet, which resulted in severe vitamin C deficiency. He received intravenous and oral vitamin C supplementation, which relieved his arthralgia and muscle pain in a week. Following 4 months of vitamin C supplementation, he demonstrated no abnormal manifestations on laboratory or imaging examination and recovered without sequelae. Inflammatory cytokine and chemokine evaluations demonstrated elevated levels of interleukin (IL)-6, IL-17A, and IL-23, which are associated with T-helper (Th) 17 cell activation. This study is the first to suggest the association between the inflammation seen in scurvy, rheumatic manifestations in the patient, and Th17 cell activation. Further analysis of the association between the inflammation and vitamin C supplementation may contribute to new insights for the comprehension and treatment of other inflammatory diseases, such as rheumatic diseases. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Ascorbic Acid Deficiency; Autism Spectrum Disorder; Child; Humans; Inflammation; Interleukin-17; Interleukin-23; Interleukin-6; Male; Scurvy | 2023 |
Triptolide and l-ascorbate palmitate co-loaded micelles for combination therapy of rheumatoid arthritis and side effect attenuation.
Triptolide (TP) has its unique curative effect in the treatment of rheumatoid arthritis (RA), but its application is limited by the poor water solubility and multi-organ toxicity. We herein developed a novel nanoparticle platform composed of L-ascorbate palmitate (VP, vitamin C derivative) that can deliver TP to synergistically treat arthritis and inhibit the occurrence of oxidative stress. The TP-loaded nanoparticles (termed TP-VP NPs) showed the suitable particle size (about 145 nm) and good physical stability. TP-VP NPs effectively down-regulated IL-1β, IL-6 and TNF-α levels to inhibit the erosion of synovitis and bone tissue, and alleviate the swelling and deformation of CIA mice's feet. Compared to the TP, TP-VP NPs could inhibit effectively the oxidative stress in liver, and alleviate significantly the triptolide-induced toxicity injury in liver, kidney and testicle. The results demonstrated that TP-VP NPs is a promising triptolide delivery system for the treatment of RA, which enhances the water solubility of TP and reduces the toxicity of TP Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Diterpenes; Epoxy Compounds; Mice; Micelles; Palmitates; Phenanthrenes; Water | 2022 |
Serum CRP, MDA, Vitamin C, and Trace Elements in Bangladeshi Patients with Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is an autoimmune disorder that is a painful health crisis. This study aimed to assess the serum C-reactive protein (CRP), malondialdehyde (MDA), non-enzymatic antioxidant (vitamin C), and trace elements (Zn, Cu, Mn, and Fe) in RA patients, and thereby correlate these parameters with the association of RA. This study included 20 Bangladeshi RA patients and 20 normal healthy volunteers as control subjects. CRP level was determined using a laboratory-based latex agglutination-enhanced immunoassay. The lipid peroxidation level was determined by measurement of the serum level of MDA. Non-enzymatic antioxidant vitamin C was assessed by UV spectrophotometric method. Trace elements were determined by atomic absorption spectroscopy (AAS). Our study observed significantly higher concentrations of CRP (p < 0.001) and MDA (p < 0.001), and significantly lower concentrations of vitamin C (p < 0.001) in the RA patient. The mean values of Zn, Cu, Mn, and Fe were 6.62 ± 0.34, 1.42 ± 0.17, 7.51 ± 0.23, and 29.25 ± 0.41 ppm for the RA patients respectively and 13.57 ± 9.13, 1.15 ± 0.17, 1.59 ± 0.18, and 62.47 ± 5.25 ppm for the control subjects, consequently. There was a significant difference (p < 0.05) in the trace element levels between the RA patients and control subjects. Our study suggests that a higher concentration of CRP and MDA, lower levels of vitamin C, and altered trace elements may be linked to RA. Topics: Arthritis, Rheumatoid; Ascorbic Acid; C-Reactive Protein; Humans; Malondialdehyde; Receptors, Immunologic; Trace Elements | 2021 |
A rare case of allergic contact dermatitis caused by 3-O-ethyl-L-ascorbic acid in skin-whitening cosmetics identified under immunosuppressive therapy.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Ascorbic Acid; Dermatitis, Allergic Contact; Erythema; Etanercept; Facial Dermatoses; Female; Humans; Immunosuppressive Agents; Methotrexate; Patch Tests; Skin Cream | 2020 |
Factors associated with the risk of gingival disease in patients with rheumatoid arthritis.
Gingival disase and rheumatoid arthritis (RA) are linked at both the epidemiologic and pathogenesis levels. In this study, we aimed to identify environmental factors associated with RA and gingival disease and to investigate factors that protect the gingival tissue in RA patients. This retrospective study analyzed 754 RA patients with gingival disease selected from the NHANES database who completed the mobile examination center interview/examination between 1999 and 2004. Data collected included demographics, lifestyle, dietary intake, and biomarkers. The study included 173 RA patients with gingival disease. Multivariate logistic regression analysis showed that the odds of gingival disease were significantly increased with male gender. However, the odds of gingival disease was significantly decreased with increased vitamin C intake (OR = 0.996, p = 0.041), and higher serum vitamin D levels (OR = 0.979, p = 0.011). Given the significant association between the prevalence of gingival disease and RA, identification of risk factors of gingival disease will be useful as a screening tool in national health surveys to improve the management of periodontal disease in patients with RA. Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Ascorbic Acid; Biomarkers; Female; Gingival Diseases; Humans; Life Style; Logistic Models; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Prevalence; Retrospective Studies; Risk Factors; Sex Factors; Vitamin D | 2017 |
Lower Healthy Eating Index-2005 dietary quality scores in older women with rheumatoid arthritis v. healthy controls.
To assess the dietary quality of older women with and without rheumatoid arthritis (RA) using the Healthy Eating Index-2005 (HEI-2005) to identify potential strategies to improve the nutritional status.. Cross-sectional. Diet was assessed using 7 d food records and analysed for nutrient composition (Food Processor v. 7.11). Diet quality was determined using the HEI-2005, a measure of compliance with 2005 US Dietary Guidelines. Individuals with RA completed a self-reported evaluation of arthritis (pain scale and disability index). Independent two-tailed t tests or Mann-Whitney tests compared the differences between groups and correlations were computed between HEI-2005 and measures of disease reactivity.. Arizona, USA.. Older (> or = 55 years) women (n 108) with RA (n 52) and healthy controls (HC; n 56).. There were no differences between groups in age, weight, or BMI (kg/m2). HC participants had higher mean HEI-2005 scores for whole fruit (cups; P = 0.02), total fruit (cups; P = 0.05), whole grains (oz; P = 0.004), oil (g; P = 0.05) and total HEI score (P = 0.04) than the RA group. In the RA group, these same HEI components were inversely correlated with disability index (r = -0.20, P = 0.04). Participants with RA reported lower mean intakes of carbohydrate (g; P = 0.02), fibre (g; P = 0.01) and vitamin C (mg; P = 0.04).. This is the first study examining the dietary quality in older women with and without RA using the HEI-2005. Living with RA was associated with significantly lower dietary quality. Since even small changes in dietary quality can translate into better nutritional status, future interventions should focus on increasing dietary quality in this high-risk group. Topics: Aged; Arizona; Arthritis, Rheumatoid; Ascorbic Acid; Cross-Sectional Studies; Diet; Diet Records; Disabled Persons; Female; Humans; Middle Aged; Reference Values; Statistics, Nonparametric; Vitamins | 2010 |
Degradation of high-molar-mass hyaluronan by ascorbate plus cupric ions: effects of D-penicillamine addition.
Pro- and anti-oxidative effects of an anti-rheumatoid drug, D-penicillamine (D-PN), on the kinetics of high-molar-mass hyaluronan (HA) degradation were monitored using the method of rotational viscometry. The degradation of the dissolved HA macromolecules was attained by applying the Weissberger's system comprising ascorbic acid plus cupric ions. Electron paramagnetic resonance (EPR) spectroscopy was used to identify the generated free radicals. The results obtained indicate that the initial anti-oxidative action of D-PN is followed by induction of pro-oxidative conditions due to the generation of reactive free radicals. It is speculated, however, that the latter situation may be considered as an advantageous property of D-PN. Hydroxyl radicals formed in this way may participate in decomposition of proteinases, which are believed to be responsible for the destruction of joint cartilage under rheumatoid arthritic conditions. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Humans; Hyaluronic Acid; Hydroxyl Radical; Penicillamine | 2009 |
[Determination of oxidation-reduction level in patients with rheumatoid arthritis].
To examine the oxidation or reduction products in patients with rheumatism arthritis (RA), and investigate the relationship between oxidation or reduction products and occurrence and development of RA.. The serum levels of total ascorbic acid (TAA), dehydroascorbic acid (DHAA)/TAA, vitamin E, advanced oxidation protein products (AOPP) and malondialdehyde (MDA) were detected by high-performance liquid chromatography with electrochemical detection in 83 RA patients and 30 healthy adults. Correlation analysis of AOPP, MDA and hs-CRP was performed.. Compared with normal control group, significantly higher serum MDA, DHAA/TAA, and AOPP levels were detected in RA patients (P<0.05), but vitamin E showed no significant difference (P<0.05). Linear regression analysis showed that MDA (P<0.01) was positively but AOPP (P>0.05) negatively correlated to hs-CRP.. Oxidation or reduction products in serum of RA patients increases significantly, which may be an important mechanism for the occurrence and development of RA. Serum AOPP and MDA levels can reflect the oxidation status in RA patients. Topics: Adult; Arthritis, Rheumatoid; Ascorbic Acid; Chromatography, High Pressure Liquid; Dehydroascorbic Acid; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Vitamin E | 2005 |
Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint.
To evaluate the dehydroascorbate (DHA) transport mechanisms in human chondrocytes.. The transport of L-(14)C-DHA in human chondrocytes was analyzed under various conditions, including the use of RNA interference (RNAi), to determine the role of glucose transporter 1 (GLUT-1) and GLUT-3 in L-14C-DHA transport and to evaluate the effects of physiologically relevant oxygen tensions on L-14C-DHA transport. In order to estimate the contributions of reduced ascorbic acid (AA) and DHA to intracellular ascorbic acid (Asc), the quantities of AA and DHA were measured in synovial fluid samples from osteoarthritis (OA) patients and compared with the reported levels in rheumatoid arthritis (RA) patients.. DHA transport in human chondrocytes was glucose-sensitive, temperature-dependent, cytochalasin B-inhibitable, modestly stereoselective for L-DHA, and up-regulated by low oxygen tension. Based on the RNAi results, GLUT-1 mediated, at least in part, the uptake of DHA, whereas GLUT-3 had a minimal effect on DHA transport. DHA constituted a mean 8% of the total Asc in the synovial fluid of OA joints, in contrast to 80% of the reported total Asc in RA joints.. We provide the first evidence that chondrocytes transport DHA via the GLUTs and that this transport mechanism is modestly selective for L-DHA. In the setting of up-regulated DHA transport at low oxygen tensions, DHA would contribute 26% of the total intracellular Asc in OA chondrocytes and 94% of that in RA chondrocytes. These results demonstrate that DHA is a physiologically relevant source of Asc for chondrocytes, particularly in the setting of an inflammatory arthritis, such as RA. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Biological Transport; Cartilage, Articular; Cell Hypoxia; Cells, Cultured; Chondrocytes; Chromatography, High Pressure Liquid; Dehydroascorbic Acid; Gene Expression; Knee Joint; Monosaccharide Transport Proteins; Osteoarthritis, Knee; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Up-Regulation | 2005 |
Vitamin C contributes to inflammation via radical generating mechanisms: a cautionary note.
Topics: Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Cardiovascular Diseases; Chronic Disease; Comorbidity; Diabetes Mellitus; Free Radicals; Gastritis; Inflammation; Oxidation-Reduction; Oxidative Stress; Pancreatitis | 2004 |
Effect of pre-loading oral glucosamine HCl/chondroitin sulfate/manganese ascorbate combination on experimental arthritis in rats.
The therapeutic effect of a nutritional supplement consisting of a combination of glucosamine hydrochloride (FCHG49), purified sodium chondroitin sulfate (TRH122), and manganese ascorbate (GCM)3 was investigated in the rat model of collagen-induced autoimmune arthritis (CIA). The GCM compound was mixed with a palatable nutritional paste (Nutri-cal [NC]). Oral administration of the NC/GCM compound was initiated in 26 rats 10 days before immunization and continued until the day of sacrifice. One group of 12 control rats was given no oral agents; a second group of 12 control rats received NC only. Evaluations included arthritis index (AI) scoring by three independent evaluators, histologic index (HI) scoring of lesions, T-cell proliferation, and serological studies for antibody classes and subclasses. Both the AI and HI criteria showed a statistically significant reduction in the prevalence of CIA in rats pretreated with the NC/GCM (54%) compared to the combined control groups (96%, chi2 analysis P = 0.001). Rats fed the NC/GCM also exhibited a significant decrease in the severity of autoimmune arthritis in both the AI and HI compared to control Group 2 (immunized-NC) (chi2 analysis P < 0.05). Histological studies verified the decreased incidence of arthritis in the NC/GCM group compared to control Group 2. GCM treatment failed to alter T-cell proliferation and antibody production to bovine type-II collagen, indicating that its effects are not due to alteration of the antigen-specific immune response. Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Autoantibodies; Chondroitin Sulfates; Collagen; Deferoxamine; Dietary Supplements; Drug Therapy, Combination; Female; Glucosamine; Knee; Manganese; Organometallic Compounds; Rats; Severity of Illness Index | 2001 |
Levels of plasma lipid peroxide products and antioxidant status in rheumatoid arthritis.
Oxygen free radicals have been implicated as mediators of tissue damage in patients with rheumatoid arthritis. The aim of our study was to assess the lipid peroxide products and antioxidant status in rheumatoid arthritis patients (RA). The study involved determination of two plasma lipid peroxide products, malondialdehyde (MDA) and conjugated dienes (CD), two plasma antioxidant vitamins (C and E) in 91 RA patients and 26 healthy subjects. The results showed that rheumatoid patients had increased plasma CD but not MDA and decreased plasma vitamin E, when properly expressed per unit cholesterol and triglyceride. This finding suggested that RA patients had increased oxidant stress that might play a role in the tissue damage and inflammation process of this disease. Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Ascorbic Acid; Female; Humans; Lipid Peroxides; Malondialdehyde; Middle Aged; Vitamin E | 2000 |
Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants.
Peroxynitrite, formed by reaction of superoxide and nitric oxide, appears to be an important tissue-damaging species generated at sites of inflammation. In this paper, we compare the abilities of several biological antioxidants to protect against peroxynitrite-dependent inactivation of alpha 1-antiproteinase, and to inhibit tyrosine nitration upon addition of peroxynitrite. GSH and ascorbate protected efficiently in both systems. Uric acid inhibited tyrosine nitration but not alpha 1-antiproteinase inactivation. The possibility that ascorbic acid is an important scavenger of reactive nitrogen species in vivo is discussed. Topics: alpha 1-Antitrypsin; Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Humans; Lipid Peroxidation; Nitrates; Oxidation-Reduction; Oxidative Stress; Pancreatic Elastase; Synovial Fluid; Tyrosine | 1996 |
Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro.
The percentage of oligosaccharide chains lacking galactose was measured in IgG obtained from pokeweed mitogen-activated cultures of blood lymphocytes from patients with rheumatoid arthritis and controls. Secreted IgG from rheumatoid arthritis lymphocytes was deficient in galactose compared with IgG from the lymphocytes of controls. This confirms that agalactosylation is a significant feature of the disease and demonstrates that it can occur at the B cell level and is not merely a post-secretory event. Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Ascorbic Acid; B-Lymphocytes; Humans; Immunoglobulin G; In Vitro Techniques; Middle Aged; Pokeweed Mitogens | 1992 |
Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates.
The ability of fresh sera to resist attack by peroxyl radicals (TRAP) was found to be significantly lower in 20 patients with rheumatoid arthritis (RA) than in 20 healthy controls, consistent with the existence of a redox stress in RA imposed by inflammation. TRAP values in RA varied inversely with a combination of visual analogue pain scale, duration of early morning stiffness, grip strength, and articular index (reflecting inflammatory activity) using multiple linear regression analysis. The concentration of the antioxidant vitamin ascorbic acid was lower in RA plasma and the oxidation-reduction equilibrium of ascorbic acid was disturbed, giving further support to the existence of a redox stress. The major determinant of TRAP in vitro was found to be serum uric acid in RA and serum vitamin E in controls. Serum urate concentration in RA correlated inversely with oxidative changes in serum albumin and IgG. It is suggested that serum urate might have an antioxidant role under certain conditions by limiting free radical induced oxidative changes to protein during inflammation. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Female; Free Radicals; Humans; Immunoglobulin G; Male; Middle Aged; Oxidation-Reduction; Oxygen; Peroxides; Serum Albumin; Uric Acid; Vitamin E | 1991 |
Vitamin C influence on localized adjuvant arthritis.
This work attempts to determine the influence of vitamin C on locally induced inflammation and arthritis in rat paws, as measured by rat paw swelling, polymorphonuclear leukocyte infiltration, pain, and surface skin temperature. Daily subcutaneous administration of 150 mg/kg of vitamin C over 20 days reduced arthritic swelling, increased pain tolerance, and decreased polymorphonuclear leukocyte infiltration, with no significant change in surface temperature. Vitamin C may provide podiatrists with a supplemental or alternative treatment for patients with rheumatoid arthritis. Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Body Temperature; Disease Models, Animal; Edema; Male; Pain; Rats; Rats, Inbred Strains | 1990 |
Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. Implications for antioxidant protection in the inflamed rheumatoid joint.
Ascorbic acid, at physiological concentrations, can scavenge the myeloperoxidase-derived oxidant hypochlorous acid at rates sufficient to protect alpha 1-antiprotease against inactivation by this molecule. The rapid depletion of ascorbic acid at sites of inflammation, as in the inflamed rheumatoid joint, may therefore facilitate proteolytic damage. Topics: alpha 1-Antitrypsin; Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Hydroxides; Hydroxyl Radical; Hypochlorous Acid; Oxidation-Reduction; Pancreatic Elastase; Peroxidase | 1987 |
Synovial fluid oxalate deposition complicating rheumatoid arthritis with amyloidosis and renal failure. Demonstration of intracellular oxalate crystals.
A patient with quiescent rheumatoid arthritis, amyloidosis and chronic renal failure developed an inflamed knee. Intracellular bipyramidal crystals characteristic of oxalate were found and are suggested as the cause of the acute arthritis. Since the patient had been treated with vitamin C, this precursor of oxalate is proposed as a possible factor in the crystal deposition. Topics: Amyloidosis; Arthritis, Rheumatoid; Ascorbic Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxalates; Oxalic Acid; Peritoneal Dialysis; Radiography; Synovial Fluid | 1987 |
Effect of functional stimulation on ascorbate content in phagocytes under physiological and pathological conditions.
Neutrophil polymorphonuclear leucocytes and macrophages contain 10-40 times increased intracellular ascorbate concentrations compared to plasma. A slight decrease of ascorbate content could be observed in total white blood cells and in monocytes upon stimulation with opsonized zymosan. These decreases were more pronounced in peritoneal and alveolar macrophages from rats. In patients with rheumatoid disease whose phagocytes are exposed to a constant challenge, significantly lowered intracellular ascorbate contents were found in neutrophils and mononuclear cells. Surgical and thermal trauma in rats depressed intracellular ascorbate levels in peritoneal macrophages. These results are indicative of an essential role ascorbic acid plays in phagocytic cells. Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Female; Humans; Macrophages; Male; Neutrophils; Phagocytes; Phagocytosis; Pulmonary Alveoli; Rats; Rats, Inbred Strains | 1986 |
The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA).
Using a novel high performance liquid chromatography (HPLC) determination of ascorbic acid and dehydroascorbic acid, we have measured the relative amounts of ascorbate and dehydroascorbate in 20 normal controls and in paired sera and synovial fluid from 13 patients with rheumatoid arthritis (RA). In complete contrast to previous published findings we were able to detect dehydroascorbate in normal human sera (12.0 +/- 3.7 mumol/l), while the mean and range of ascorbate measured in normals was 69.6 +/- 20.6 mumol/l. These findings were completely reversed in rheumatoid sera (21.8 +/- 8.6 mumol/l and 5.1 +/- 5.0 mumol/l for dehydroascorbate and ascorbic acid respectively). In several rheumatoid sera no ascorbate could be detected. In paired synovial fluid and serum samples, there was always more dehydroascorbate detected in synovial fluids than in the corresponding sera (p less than 0.01). The data suggests that the reduced level of ascorbate and increased level of dehydroascorbate may be a reflection of the increased antioxidant and free-radical scavenging activity of the vitamin in RA, especially within the inflamed joint. Topics: Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Chromatography, High Pressure Liquid; Dehydroascorbic Acid; Humans; Middle Aged; Synovial Fluid | 1985 |
Formation of hydroxyl radicals from hydrogen peroxide and iron salts by superoxide- and ascorbate-dependent mechanisms: relevance to the pathology of rheumatoid disease.
1. Superoxide and hydrogen peroxide are formed by activated phagocytes and react together in the presence of iron salts to form the hydroxyl radical, which attacks hyaluronic acid. Ascorbic acid also interacts with hydrogen peroxide and iron salts to form hydroxyl radical in a reaction independent of superoxide. Since iron salts, ascorbate and activated phagocytes are present in the rheumatoid joint, experiments were designed to see whether ascorbate-dependent or superoxide-dependent formation of hydroxyl radicals would be more important in vivo. 2. In the present study, addition of ascorbate to a superoxide-generating system at concentrations of 100 mumol/l provoked a superoxide-independent formation of hydroxyl radicals for a short period. Lower concentrations of ascorbate did not do this. It is therefore suggested that the superoxide-dependent reaction is probably more important. 3. It is further suggested that destruction of ascorbate by oxygen radicals formed by activated phagocytes accounts for the previously reported low concentrations of this compound in the serum and synovial fluid of rheumatoid patients. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Chemical Phenomena; Chemistry; Ferric Compounds; Free Radicals; Humans; Hydrogen Peroxide; Hydroxylation; Iron; Oxygen; Phagocytes; Superoxides | 1983 |
Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid.
20 patients with active rheumatoid arthritis were treated for 12 weeks with the prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid in the form of primrose evening oil (Efamol) and the co-factors zinc, ascorbic acid, niacin, and pyridoxin (Efavit). There was a slight fall in skin reactivity to UV light during the treatment, but no effect on plasma or urine concentrations of PGE1, cAMP or cGMP. There was no effect of the treatment on ESR, P-fibrinogen, number of tender joints, number of swollen joints, the duration of morning stiffness, or on the patient's estimation of pain. Topics: Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Cyclic AMP; Cyclic GMP; Drug Combinations; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; gamma-Linolenic Acid; Humans; Linoleic Acids; Male; Middle Aged; Niacin; Oenothera biennis; Plant Oils; Prostaglandins E; Pyridoxine; Radioimmunoassay; Skin; Ultraviolet Rays; Zinc; Zinc Compounds | 1983 |
Control trials of dimethyl sulfoxide in rheumatoid and collagen diseases.
Topics: Adolescent; Adult; Aged; Amyloidosis; Arthritis, Juvenile; Arthritis, Rheumatoid; Ascorbic Acid; Child; Child, Preschool; Dimethyl Sulfoxide; Drug Evaluation; Glomerular Filtration Rate; Humans; Kidney; Middle Aged; Proteinuria; Scleroderma, Systemic; Sjogren's Syndrome; Ultrasonics | 1983 |
[Capillary circulation and various indices of tissue metabolism in patients with rheumatoid arthritis].
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Ascorbic Acid; Capillary Permeability; Female; Humans; Iron; Male; Middle Aged | 1983 |
Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses.
Topics: Adult; Arthritis, Rheumatoid; Ascorbic Acid; B-Lymphocytes; Chediak-Higashi Syndrome; Concanavalin A; Cyclic GMP; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulins; In Vitro Techniques; Lymphocytes; Middle Aged; Monocytes; Pokeweed Mitogens; T-Lymphocytes, Regulatory | 1982 |
The role of superoxide and hydroxyl radicals in the degradation of hyaluronic acid induced by metal ions and by ascorbic acid.
Purified commercial hyaluronic acid contains significant amounts of iron. Addition of Fe2+ to solutions of it causes depolymerization, which is inhibited by catalase and scavengers of the hydroxyl radical (. OH) but not by superoxide dismutase. Fe3+ is ineffective. Ascorbic acid also depolymerizes hyaluronic acid, apparently because it can reduce Fe3+ in the reaction mixtures to Fe2+. Ascorbate-induced depolymerization is inhibited by the specific iron chelator desferrioxamine, by catalase, and by scavengers of the hydroxyl radical. The relevance of these observations to rheumatoid arthritis and inflammatory joint diseases is discussed. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Chemical Phenomena; Chemistry; Free Radicals; Humans; Hyaluronic Acid; Iron; Superoxides; Synovial Fluid | 1981 |
Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients.
1. On exposure of synovial fluid to superoxide and hydrogen peroxide, generated enzymically or by activated polymorphonuclear leucocytes, hyaluronic acid is depolymerized and the fluid loses its lubricating properties. The ability of synovial fluid from rheumatoid patients to scavenge superoxide and hydrogen peroxide was therefore examined. 2. Synovial fluid from a range of rheumatoid patients contained no superoxide dismutase activity, insufficient caeruloplasmin to scavenge any superoxide radical and little, if any, catalase activity. 3. Total ascorbate (reduced ascorbate + dehydroascorbate) concentrations in the plasma and synovial fluid of rheumatoid patients were similar in each case. The values are at the low end of the normal range. 4. These results are discussed in relation to the role of oxygen radicals in inflammatory joint disease. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Catalase; Humans; Superoxide Dismutase; Synovial Fluid | 1981 |
Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C.
Lack of adequate synthesis of prostaglandin (PG) E1 may be the key factor in Sjogren's syndrome. PGE1 is important for lacrimal and salivary gland secretion and for T lymphocyte function: a deficiency could therefore account for the main features of Sjogren's syndrome and the sicca syndrome. PGE1 could also account for many of the other features often associated with these syndromes. These include the Raynaud's phenomenon, the abnormalities of renal function and the precipitation of the syndrome by vitamin C deficiency. Vitamin C is important in PGE1 biosynthesis. PGE1 treatment has been shown to correct the immunological abnormalities in the NZB/W mouse, the animal model of Sjogren's syndrome. An attempt to treat humans with Sjogren's syndrome by raising endogenous PGE1 production by administration of essential fatty acid PGE1 precursors, of pyridoxine and of vitamin C was successful in raising the rates of tear and saliva production. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Fatty Acids, Essential; Female; Humans; Lacrimal Apparatus Diseases; Middle Aged; Prostaglandins E; Pyridoxine; Salivary Gland Diseases; Sjogren's Syndrome; Syndrome | 1980 |
Effect of ascorbic acid on prolyl hydroxylase activity, collagen hydroxylation and collagen synthesis in human synovial cells in culture.
Synovial cells derived from patients with either rheumatoid arthritis, or simple joint-trauma were grown in tissue culture. The rheumatoid osteoarthritic and non-arthritic synovial cells in cultured all had similar levels of prolyl hydroxylase activity. Following a 3 hour incubation with ascorbate (10(-4)M), prolyl hydroxylase activity was elevated to a similar extent in all synovial cell cultures examined. The activation of prolyl hydroxylase by ascorbate (10(-4)M) was accompanied by increased radioactive hydroxyproline formation and secretion into the media. Increased amounts of collagenase degradable radioactive protein were also secreted into the media, but no changes in total collagen synthesis (media plus cell layer) were observed as a result of ascorbate supplementation using this assay system. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Cells, Cultured; Collagen; Humans; Hydroxylation; Hydroxyproline; Procollagen-Proline Dioxygenase; Proteins; Synovial Fluid | 1979 |
Effect of aspirin and vitamins C and E on synovial rheumatoid arthritic and other cells.
Normal and rheumatoid arthritic human synovial cells, normal rat muscle and bone cells, were cultured with combinations of aspirin (acetylsalicytic acid), vitamins C and E. Aspirin reduced percent growth of all cells by about 1/5 relative to controls. High vitamin C eradicated arthritic cells. In combinations, vitamin C was most important in eradicating arthritic cells. A low-vitamin C combination was most effective in reducing arthritic cell populations, while having little effect on normal cells. Vitamin E retarded but did not prevent the action of vitamin C. Topics: Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Bone and Bones; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Humans; Muscles; Synovial Fluid; Vitamin E | 1979 |
The metabolism of ascorbic acid in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Female; Humans; Leukocytes; Male; Middle Aged | 1976 |
Chronic disease and disability: rheumatoid arthritis.
Topics: Activities of Daily Living; Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Disabled Persons; Female; Foot; Gold; Hand; Humans; Interpersonal Relations; Joint Prosthesis; Knee; Middle Aged; Phenylbutazone; Prednisone; Radiography; Synovectomy | 1974 |
[Problem of vitamin A and C resorption in patients with rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Female; Humans; Intestinal Absorption; Male; Middle Aged; Vitamin A | 1974 |
The effect of experimentally induced redox changes on human rheumatoid and non-rheumatoid synovial tissue in vitro.
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Culture Techniques; Cytoplasm; Extracellular Space; Humans; Hydrogen-Ion Concentration; Lysosomes; NADP; Oxidation-Reduction; Synovial Membrane; Vitamin K | 1973 |
[Level of vitamins C, A, E and beta carotene in patients with progressive polyarthritis].
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Carotenoids; Female; Humans; Iron; Male; Middle Aged; Vitamin A; Vitamin E | 1973 |
Effect of aspirin ingestion on ascorbic-acid levels in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Ascorbic Acid Deficiency; Aspirin; Blood Platelets; Humans; Middle Aged | 1971 |
[Effects of a triamcinolone-salicylamide combination in painful diseases of supporting system. Summarized experiences of 45 residential physicians].
Topics: Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Drug Synergism; Female; Humans; Male; Middle Aged; Muscular Diseases; Neuralgia; Pain; Salicylamides; Spinal Diseases; Surveys and Questionnaires; Triamcinolone | 1971 |
Increased protocollagen proline hydroxylase activity in synovial tissue in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Biopsy; Carbon Isotopes; Collagen; Humans; Iron; Ketoglutaric Acids; Mixed Function Oxygenases; Oxygen; Proline; Synovial Membrane | 1970 |
Degradation of synovial fluid and hyaluronic acid by serum and testicular hyaluronidase, and by L-ascorbic acid and the effect of inhibitors.
Topics: Adult; Alcohols; Animals; Arthritis, Rheumatoid; Ascorbic Acid; Cattle; Chemical Phenomena; Chemistry; Gold; Hexosamines; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Iodoacetates; Male; Oligosaccharides; Penicillamine; Sulfur; Synovial Fluid; Testis; Thiomalates; Viscosity | 1969 |
[Clinical evaluation of the preparation Heptuna Plus].
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Humans; Iron; Rheumatic Fever; Vitamins | 1969 |
The use of "Myocrisin".
Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Dog Diseases; Dogs; Gold; Horse Diseases; Horses | 1969 |
Inhibition of ascorbic-acid-induced depolymerization of hyaluronic acid by ceruloplasmin in synovial fluid.
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Ceruloplasmin; Chemical Phenomena; Chemistry; Hepatolenticular Degeneration; Humans; Hyaluronic Acid; Synovial Fluid; Viscosity | 1968 |
[Modern anti-inflammatory and analgesic treatment with sodium oxyferriscorbone. Clinical observations in Rumania].
Topics: Adult; Aged; Arthritis, Rheumatoid; Ascorbic Acid; Female; Humans; Iron; Male; Peptic Ulcer; Romania | 1967 |
[The incidence of cervical vertebrae and shoulder joint lesions in patients with spondylitis ankylopoetica].
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Blood Sedimentation; Cervical Vertebrae; Galvanic Skin Response; Humans; Male; Physical Fitness; Prostate; Shoulder Joint; Spondylitis, Ankylosing | 1966 |
Dermal connective tissue permeability in rheumatoid arthritics.
Topics: Adult; Animals; Arthritis, Rheumatoid; Ascorbic Acid; Carbamates; Cell Membrane Permeability; Connective Tissue; Cysteine; Dye Dilution Technique; Ethanol; Humans; Hyaluronic Acid; Injections, Intradermal; Isotonic Solutions; Penicillamine; Prednisone; Rats; Skin; Sodium Salicylate; Thiourea | 1966 |
[Intermittent treatment of primary chronic polyarthritis].
Topics: Acetylcholine; Adrenocorticotropic Hormone; Antistreptolysin; Arthritis, Rheumatoid; Ascorbic Acid; Blood Protein Electrophoresis; Blood Sedimentation; Fructose; Hemagglutination Tests; Humans; Leukocyte Count; Phenylbutazone; Pyridines; Pyridostigmine Bromide | 1965 |
[Positive Uroscreen test caused by treatment with ascorbic acid].
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Humans; Middle Aged; Urine | 1965 |
SIMULTANEOUS SALICYLATE CONCENTRATIONS IN SYNOVIAL FLUID AND PLASMA IN RHEUMATOID ARTHRITIS.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Blood Chemical Analysis; Humans; Knee; Plasma; Proteins; Salicylates; Serum Albumin; Synovial Fluid | 1964 |
EFFECT OF ASCORBIC ACID ON RHEUMATOID SYNOVIAL FLUID.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Blood Protein Electrophoresis; Hemagglutination Inhibition Tests; Humans; Hyaluronic Acid; Knee; Synovial Fluid | 1964 |
[SOME THERAPEUTIC TRIALS IN RHEUMATOLOGY].
Topics: Anticoagulants; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Gout; Hip Joint; Humans; Joint Diseases; Rheumatology; Spondylitis; Spondylitis, Ankylosing | 1964 |
[Ascorbic acid in whole blood in rheumatoid arthritis in children].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid | 1963 |
[PSORIASIS AND RHEUMATIC MANIFESTATIONS].
Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Gout; Humans; Psoriasis; Spondylitis; Spondylitis, Ankylosing; Sunlight; Triamcinolone; Ultraviolet Rays; Vitamin A | 1963 |
[Alteration of tyrosine metabolism with vitamin C in primary chronic polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Blood Proteins; Blood Sedimentation; Humans; Tyrosine; Vitamins | 1962 |
[Some indices of the vitamin balance in patients with arthritis-arthroses].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Body Fluids; Humans; Joint Diseases; Thiamine; Vitamins | 1962 |
[Clinical trial of pabegan in rheumatoid arthritis].
Topics: 4-Aminobenzoic Acid; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Niacin; Nicotinic Acids; Vitamins | 1959 |
The use of sigmagen in the treatment of rheumatoid diseases.
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Humans; Prednisolone; Rheumatic Diseases; Vitamins | 1957 |
[Therapeutic effect of prednisone-salicylamide-ascorbic acid combination (prednicyl) in rheumatic polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Humans; Prednisone; Salicylamides; Vitamins | 1957 |
[Treatment of primary chronic polyarthritis with nitrogen mustards].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Mechlorethamine; Nitrogen Mustard Compounds; Vitamins | 1957 |
[High dose vitamin C in therapy of chronic polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1956 |
[Combined treatment of chronic rheumatoid arthritis with gold and high doses of vitamin C].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Combined Modality Therapy; Gold; Vitamins | 1956 |
Seven-year observations on the treatment of arthritis with hesperidin-ascorbic acid.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Flavones; Hesperidin; Osteoarthritis; Vitamins | 1956 |
[Clinical experience with decortisal in rheumatic joint diseases].
Topics: Antacids; Arthritis; Arthritis, Reactive; Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Prednisone; Vitamins | 1956 |
A new form of drug therapy in the treatment of arthritis and rheumatoid conditions.
Topics: Anthelmintics; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Mephenesin; Salicylates; Vitamins | 1954 |
[Study of the use of ascorbic acid in rheumatoid arthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1954 |
[Promising therapeutic possibilities of combined ACTH, ATP and ascorbic acid].
Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Humans; Hypersensitivity; Rheumatic Diseases | 1954 |
[Effect of sodium salicylate and vitamin C on mineral and carbohydrate metabolism, on uric acid level and on leukocyte count in rheumatism].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Carbohydrate Metabolism; Electrolytes; Humans; Leukocyte Count; Minerals; Rheumatic Diseases; Salicylates; Sodium Salicylate; Uric Acid | 1954 |
[Eosinophils in rheumatoid arthritis following quartz and sollux lamps irradiation with simultaneous intravenous administration of vitamin C].
Topics: Administration, Intravenous; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Eosinophils; Humans; Infrared Rays; Leukocyte Count; Quartz; Ultraviolet Rays; Ultraviolet Therapy; Vitamins | 1954 |
[Combination of cortisone and ascorbic acid in the treatment of rheumatoid arthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Vitamins | 1953 |
[Terramycin, cortisone, ascorbic acid in therapy of chronic evolutive polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Oxytetracycline; Vitamins | 1953 |
[Capillary permeability for blood proteins in rheumatoid arthritis before and after application of desoxycorticosterone acetate and ascorbic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Blood Proteins; Capillary Permeability; Desoxycorticosterone; Desoxycorticosterone Acetate | 1952 |
An evaluation of pregnenolone and a combination of desoxycorticosterone acetate-sodium ascorbate in the treatment of arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Pregnenolone; Vitamins | 1952 |
[Study on a case of chronic polyarthritis treated with DOCA and ascorbic acid, cortisone per os, parenteral cortisone, and ACTH; considerations on so-called suspension syndrome].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Desoxycorticosterone Acetate; Vitamins | 1952 |
[Ascorbic acid in treatment of polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1952 |
Ascorbic acid and formaldehyde-irritation arthritis in the adrenalectomized rat.
Topics: Adrenal Glands; Animals; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Formaldehyde; Rats; Respiratory Hypersensitivity | 1952 |
[Desoxycorticosterone acetate and vitamin C in rheumatic diseases].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Rheumatic Diseases; Vitamins | 1952 |
[Associated steroids with vitamin C in degenerative chronic rheumatism; studies on the mechanism of action].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Rheumatic Diseases; Steroids | 1952 |
[Development of diabetes mellitus after DOCA-vitamin C therapy of chronic polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Diabetes Mellitus; Vitamins | 1952 |
Assessment of rapidly acting agents in rheumatoid arthritis; observations on deoxycortone with ascorbic acid, A.C.T.H., and cortisone.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone | 1952 |
[Associated steroids-ascorbic acid in certain chronic arthropathies].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Steroids; Vitamins | 1952 |
[Effects of desoxycorticosterone vitamin C and cortisone on the formalin arthritis of the rat].
Topics: Animals; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Desoxycorticosterone; Formaldehyde; Rats; Vitamins | 1952 |
[Studies on a case of rheumatoid arthritis associated with psoriasis treated with DOCA, DOCA and ascorbic acid, and ACTH].
Topics: Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Psoriasis; Vitamins | 1952 |
[Therapy of polyarthritis rheumatica with desoxycorticosterone acetate and 1-ascorbic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Rheumatic Fever; Vitamins | 1951 |
Combined administration of desoxycorticosterone acetate and ascorbic acid. I. Clinical results in rheumatoid arthritis and laboratory studies.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1951 |
The effect of some steroids (testosterone propionate, desoxycorticosterone acetate and ascorbic acid, and 21-acetoxy delta-5-pregnenolone, artisone acetate, Wyeth) in rheumatoid arthritis.
Topics: Acetates; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Pregnenolone; Steroids; Testosterone Propionate | 1951 |
Deoxycortone acetate and ascorbic acid in rheumatoid arthritis.
Topics: Acetates; Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1951 |
Desoxycorticosterone acetate and ascorbic acid in the treatment of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1951 |
The effect of ACTH, cortisone, and DCA with ascorbic acid on "formalin-arthritis".
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Formaldehyde; Vitamins | 1951 |
[Effect of cortisone, pregnenolone and desoxycorticosterone with 1-ascorbic acid on urinary excretion of nitrogen and sulfur].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Desoxycorticosterone; Nitrogen; Pregnenolone; Sulfur | 1951 |
[12 Cases of non-specific inflammatory articular lesions treated with the Lewin and Wassen technic].
Topics: Aged; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Humans; Vitamins | 1951 |
[Marked improvement of chronic polyarthritis in two patients treated with a combination of desoxycorticosterone acetate, ascorbic acid and sex hormones].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Gonadal Steroid Hormones | 1951 |
[Certain cases of joint diseases treated by desoxycorticosterone and vitamin C].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Joint Diseases | 1951 |
[Rheumatic or rheumatoid arthritis treated with desoxycorticosterone and vitamin C].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Vitamins | 1951 |
[Corticosterone and ascorbic acid in the treatment of rheumatoid arthritis and chronic rheumatisms].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Corticosterone; Rheumatic Diseases | 1951 |
[Therapy of primary chronic arthritis with desoxycorticosterone acetate and ascorbic acid].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1951 |
Desoxycorticosterone acetate and vitamin C in rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1951 |
[Release of diabetes mellitus by desoxycorticosterone and vitamin C therapy of polyarthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Diabetes Mellitus; Humans; Vitamins | 1951 |
Desoxycorticosterone acetate and ascorbic acid in arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate | 1951 |
[Treatment of rheumatoid arthritis with desoxycorticosterone and ascorbic acid].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Vitamins | 1951 |
[High doses of ascorbic acid in rheumatoid arthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1951 |
[Treatment of rheumatoid arthritis with DOCA and ascorbic acid].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1951 |
[Treatment of chronic articular rheumatism with adrenal cortex extracts].
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Vitamins | 1951 |
[Treatment of rheumatoid arthritis with steroid hormones].
Topics: Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Steroids; Vitamins | 1951 |
[Experiences with desoxycorticosterone and ascorbic acid in rheumatoid arthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone | 1951 |
[Combined corticosterone-vitamin-C therapy in rheumatoid arthritis].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Corticosterone; Desoxycorticosterone; Psychotherapy, Multiple; Vitamins | 1951 |
[Combined steroid and vitamin C in rheumatoid arthritis; research on the mechanism of it action].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Hormones; Steroids; Vitamins | 1951 |
Effect of ascorbic acid, potassium chloride flooding, and cortisone on the course of formaldehyde-irritation arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Formaldehyde; Potassium; Potassium Chloride; Vitamins | 1951 |
Desoxycorticosterone acetate and ascorbic acid in the treatment of rheumatoid arthritis, osteoarthritis, spondylitis and acute sciatica.
Topics: Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Disease; Humans; Osteoarthritis; Sciatic Nerve; Sciatica; Spondylitis | 1951 |
The effect of deoxycortone and ascorbic acid on experimental arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone; Desoxycorticosterone; Humans; Vitamins | 1951 |
[Behavior of eosinophils and other leukocytes in diseases of the joints treated with DOCA and ascorbic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Desoxycorticosterone Acetate; Eosinophils; Joints; Leukocyte Count; Leukocytes | 1951 |
[Treatment of rheumatoid arthritis with desoxycorticosterone and ascorbic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Vitamins | 1951 |
Clinical assessment of rapidly acting agents in rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1950 |
[Lewin and Wassen method; 21 cases of inflammatory polyarthritis treated without results].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Vitamins | 1950 |
[Symptomatic treatment of rheumatoid arthritis with desoxycorticosterone and ascorbic acid; report of a case; experimental check on the effects on leukocyte formula in the rat].
Topics: Adrenal Cortex Hormones; Animals; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Leukocytes; Rats | 1950 |
Effect of desoxycorticosterone and ascorbic acid on rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Vitamins | 1950 |
A case report of the use of combined DOCA and ascorbic acid in a 12-year-old child with rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1950 |
[Effects of desocycorticosterone and ascorbic acid in rheumatoid arthritis and other rheumatic diseases].
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Ascorbic Acid; Rheumatic Diseases; Vitamins | 1950 |
Observations on the effect of combined injections of desoxycorticosterone acetate and ascorbic acid on rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1950 |
[Effect of combined desoxycorticosterone acetate and ascorbic acid in therapy of pathological disorders of muscle function].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Muscles; Vitamins | 1950 |
[Treatment of rheumatoid arthritis with desoxycorticosterone acetate and ascorbic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate | 1950 |
PRESENT status of percorten and ascorbic acid in rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone | 1950 |
[Results obtained with desoxycorticosterone and ascorbic acid in rheumatoid arthritis and other rheumatic pictures].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Rheumatic Diseases | 1950 |
[Desoxycorticosterone acetate and vitamin C in the treatment of rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Vitamins | 1950 |
[Variations of the alkaline reserve and of the electrolyte balance in arthropathic subjects subjected to combined treatment with desoxycorticosterone acetate and ascorbic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Joint Diseases; Water-Electrolyte Balance | 1950 |
[Results obtained with desoxycorticosterone and ascorbic acid in rheumatoid arthritis and other rheumatic diseases].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Rheumatic Diseases | 1950 |
Steroid therapy in rheumatoid arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Steroids; Vitamins | 1950 |
Treatment of rheumatoid arthritis with deoxycortone and vitamin C.
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Tissue Extracts; Vitamins | 1950 |
Desoxycorticosterone acetate and ascorbic acid in the treatment of rheumatoid arthritis.
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Tissue Extracts | 1950 |
Deoxycortone and ascorbic acid in the treatment of rheumatoid arthritis.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Tissue Extracts; Vitamins | 1950 |
[Therapeutic action of ascorbic acid in rheumatic diseases].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Rheumatic Diseases; Vitamins | 1950 |
Desoxycorticosterone acetate and ascorbic acid injections in rheumatoid arthritis.
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Tissue Extracts | 1950 |
A.C.T.H. in rheumatoid arthritis compared with intramuscular adrenaline and with deoxycortone and ascorbic acid.
Topics: Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Epinephrine; Injections, Intramuscular; Vitamins | 1950 |
[Phenyl-quinolincarbonic acid, associated with vitamin C and nicotinamide in the therapy of joint disease].
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Humans; Joint Diseases; Niacin; Niacinamide | 1950 |
Rheumatoid arthritis: results of treatment with desoxycorticosterone acetate and ascorbic acid (arthrodox).
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Tissue Extracts | 1950 |
[The treatment of arthropathy with combined injections of desoxycorticosterone and ascorbic acid (method of Lewin and Wassén) personal experience].
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Joint Diseases; Tissue Extracts | 1950 |
[Desoxycorticosterone acetate and ascorbic acid in the treatment of rheumatoid arthritis].
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone Acetate; Tissue Extracts | 1950 |
[Treatment of arthropathies with desoxycorticosterone and ascorbic acid (Lewin and Wassen method); critical and analytical study; personal experience].
Topics: Adrenal Cortex; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Desoxycorticosterone; Joint Diseases; Tissue Extracts | 1950 |
The synergistic effect of massive doses of ascorbic acid when combined with gold in the treatment of rheumatoid arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Gold; Organogold Compounds; Vitamins | 1949 |
Effect of combined injections of deoxycortone acetate and ascorbic acid on rheumatoid arthritis.
Topics: Acetates; Adrenal Glands; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Injections; Tissue Extracts; Vitamins | 1949 |
Deoxycortone acetate and ascorbic acid in the treatment of rheumatoid arthritis.
Topics: Acetates; Adrenal Glands; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Tissue Extracts; Vitamins | 1949 |
Deoxycortone with ascorbic acid versus adrenocorticotropic hormone in rheumatoid arthritis.
Topics: Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Cortisone | 1949 |
Effect of hesperidin and ascorbic acid on capillary fragility in rheumatoid arthritis; a preliminary report.
Topics: Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Blood Vessels; Capillaries; Capillary Fragility; Cardiovascular System; Hesperidin; Humans | 1946 |